The global Classical Swine Fever Vaccines market size was valued at US$ 173 million in 2024 and is forecast to a readjusted size of USD 234 million by 2031 with a CAGR of 4.5% during review period.
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global classical swine fever vaccine market is dominated by Winsun, Boehringer Ingelheim and CAHIC, with the top three manufacturers accounting for about 37% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 70%, followed by Europe with a market share of about 15%. Tissue Culture Origin is the main type, with a share about 66%. 麻豆原创 Sales is the main application, which holds a share about 95%.
This report is a detailed and comprehensive analysis for global Classical Swine Fever Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Source and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Classical Swine Fever Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/K Doses), 2020-2031
Global Classical Swine Fever Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/K Doses), 2020-2031
Global Classical Swine Fever Vaccines market size and forecasts, by Source and by Sales Channel, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/K Doses), 2020-2031
Global Classical Swine Fever Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (US$/K Doses), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Classical Swine Fever Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Classical Swine Fever Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include WINSUN, Merck, CAHIC, Tecon, SPAH, Boehringer Ingelheim, Ceva, Harbin Veterinary Research Institute, Qilu Animal Health Products Factory, Ringpu Biology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Classical Swine Fever Vaccines market is split by Source and by Sales Channel. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Source, and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Source
Tissue Culture Origin
Cell Line Origin
麻豆原创 segment by Sales Channel
Government Tender
麻豆原创 Sales
Major players covered
WINSUN
Merck
CAHIC
Tecon
SPAH
Boehringer Ingelheim
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Classical Swine Fever Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Classical Swine Fever Vaccines, with price, sales quantity, revenue, and global market share of Classical Swine Fever Vaccines from 2020 to 2025.
Chapter 3, the Classical Swine Fever Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Classical Swine Fever Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Source and by Sales Channel, with sales market share and growth rate by Source, by Sales Channel, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Classical Swine Fever Vaccines market forecast, by regions, by Source, and by Sales Channel, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Classical Swine Fever Vaccines.
Chapter 14 and 15, to describe Classical Swine Fever Vaccines sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Source
1.3.1 Overview: Global Classical Swine Fever Vaccines Consumption Value by Source: 2020 Versus 2024 Versus 2031
1.3.2 Tissue Culture Origin
1.3.3 Cell Line Origin
1.4 麻豆原创 Analysis by Sales Channel
1.4.1 Overview: Global Classical Swine Fever Vaccines Consumption Value by Sales Channel: 2020 Versus 2024 Versus 2031
1.4.2 Government Tender
1.4.3 麻豆原创 Sales
1.5 Global Classical Swine Fever Vaccines 麻豆原创 Size & Forecast
1.5.1 Global Classical Swine Fever Vaccines Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Classical Swine Fever Vaccines Sales Quantity (2020-2031)
1.5.3 Global Classical Swine Fever Vaccines Average Price (2020-2031)
2 Manufacturers Profiles
2.1 WINSUN
2.1.1 WINSUN Details
2.1.2 WINSUN Major Business
2.1.3 WINSUN Classical Swine Fever Vaccines Product and Services
2.1.4 WINSUN Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 WINSUN Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Classical Swine Fever Vaccines Product and Services
2.2.4 Merck Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Merck Recent Developments/Updates
2.3 CAHIC
2.3.1 CAHIC Details
2.3.2 CAHIC Major Business
2.3.3 CAHIC Classical Swine Fever Vaccines Product and Services
2.3.4 CAHIC Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 CAHIC Recent Developments/Updates
2.4 Tecon
2.4.1 Tecon Details
2.4.2 Tecon Major Business
2.4.3 Tecon Classical Swine Fever Vaccines Product and Services
2.4.4 Tecon Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Tecon Recent Developments/Updates
2.5 SPAH
2.5.1 SPAH Details
2.5.2 SPAH Major Business
2.5.3 SPAH Classical Swine Fever Vaccines Product and Services
2.5.4 SPAH Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 SPAH Recent Developments/Updates
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Classical Swine Fever Vaccines Product and Services
2.6.4 Boehringer Ingelheim Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Boehringer Ingelheim Recent Developments/Updates
2.7 Ceva
2.7.1 Ceva Details
2.7.2 Ceva Major Business
2.7.3 Ceva Classical Swine Fever Vaccines Product and Services
2.7.4 Ceva Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Ceva Recent Developments/Updates
2.8 Harbin Veterinary Research Institute
2.8.1 Harbin Veterinary Research Institute Details
2.8.2 Harbin Veterinary Research Institute Major Business
2.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product and Services
2.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Harbin Veterinary Research Institute Recent Developments/Updates
2.9 Qilu Animal Health Products Factory
2.9.1 Qilu Animal Health Products Factory Details
2.9.2 Qilu Animal Health Products Factory Major Business
2.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product and Services
2.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Qilu Animal Health Products Factory Recent Developments/Updates
2.10 Ringpu Biology
2.10.1 Ringpu Biology Details
2.10.2 Ringpu Biology Major Business
2.10.3 Ringpu Biology Classical Swine Fever Vaccines Product and Services
2.10.4 Ringpu Biology Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Ringpu Biology Recent Developments/Updates
2.11 DHN
2.11.1 DHN Details
2.11.2 DHN Major Business
2.11.3 DHN Classical Swine Fever Vaccines Product and Services
2.11.4 DHN Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 DHN Recent Developments/Updates
2.12 CAVAC
2.12.1 CAVAC Details
2.12.2 CAVAC Major Business
2.12.3 CAVAC Classical Swine Fever Vaccines Product and Services
2.12.4 CAVAC Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 CAVAC Recent Developments/Updates
2.13 Komipharm
2.13.1 Komipharm Details
2.13.2 Komipharm Major Business
2.13.3 Komipharm Classical Swine Fever Vaccines Product and Services
2.13.4 Komipharm Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Komipharm Recent Developments/Updates
2.14 Agrovet
2.14.1 Agrovet Details
2.14.2 Agrovet Major Business
2.14.3 Agrovet Classical Swine Fever Vaccines Product and Services
2.14.4 Agrovet Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Agrovet Recent Developments/Updates
2.15 Bioveta
2.15.1 Bioveta Details
2.15.2 Bioveta Major Business
2.15.3 Bioveta Classical Swine Fever Vaccines Product and Services
2.15.4 Bioveta Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Bioveta Recent Developments/Updates
2.16 Jinyu Bio-Technology
2.16.1 Jinyu Bio-Technology Details
2.16.2 Jinyu Bio-Technology Major Business
2.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Product and Services
2.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Jinyu Bio-Technology Recent Developments/Updates
2.17 Institutul Pasteur
2.17.1 Institutul Pasteur Details
2.17.2 Institutul Pasteur Major Business
2.17.3 Institutul Pasteur Classical Swine Fever Vaccines Product and Services
2.17.4 Institutul Pasteur Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Institutul Pasteur Recent Developments/Updates
2.18 MVP
2.18.1 MVP Details
2.18.2 MVP Major Business
2.18.3 MVP Classical Swine Fever Vaccines Product and Services
2.18.4 MVP Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 MVP Recent Developments/Updates
3 Competitive Environment: Classical Swine Fever Vaccines by Manufacturer
3.1 Global Classical Swine Fever Vaccines Sales Quantity by Manufacturer (2020-2025)
3.2 Global Classical Swine Fever Vaccines Revenue by Manufacturer (2020-2025)
3.3 Global Classical Swine Fever Vaccines Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Classical Swine Fever Vaccines by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Classical Swine Fever Vaccines Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Classical Swine Fever Vaccines Manufacturer 麻豆原创 Share in 2024
3.5 Classical Swine Fever Vaccines 麻豆原创: Overall Company Footprint Analysis
3.5.1 Classical Swine Fever Vaccines 麻豆原创: Region Footprint
3.5.2 Classical Swine Fever Vaccines 麻豆原创: Company Product Type Footprint
3.5.3 Classical Swine Fever Vaccines 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Classical Swine Fever Vaccines 麻豆原创 Size by Region
4.1.1 Global Classical Swine Fever Vaccines Sales Quantity by Region (2020-2031)
4.1.2 Global Classical Swine Fever Vaccines Consumption Value by Region (2020-2031)
4.1.3 Global Classical Swine Fever Vaccines Average Price by Region (2020-2031)
4.2 North America Classical Swine Fever Vaccines Consumption Value (2020-2031)
4.3 Europe Classical Swine Fever Vaccines Consumption Value (2020-2031)
4.4 Asia-Pacific Classical Swine Fever Vaccines Consumption Value (2020-2031)
4.5 South America Classical Swine Fever Vaccines Consumption Value (2020-2031)
4.6 Middle East & Africa Classical Swine Fever Vaccines Consumption Value (2020-2031)
5 麻豆原创 Segment by Source
5.1 Global Classical Swine Fever Vaccines Sales Quantity by Source (2020-2031)
5.2 Global Classical Swine Fever Vaccines Consumption Value by Source (2020-2031)
5.3 Global Classical Swine Fever Vaccines Average Price by Source (2020-2031)
6 麻豆原创 Segment by Sales Channel
6.1 Global Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2020-2031)
6.2 Global Classical Swine Fever Vaccines Consumption Value by Sales Channel (2020-2031)
6.3 Global Classical Swine Fever Vaccines Average Price by Sales Channel (2020-2031)
7 North America
7.1 North America Classical Swine Fever Vaccines Sales Quantity by Source (2020-2031)
7.2 North America Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2020-2031)
7.3 North America Classical Swine Fever Vaccines 麻豆原创 Size by Country
7.3.1 North America Classical Swine Fever Vaccines Sales Quantity by Country (2020-2031)
7.3.2 North America Classical Swine Fever Vaccines Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Classical Swine Fever Vaccines Sales Quantity by Source (2020-2031)
8.2 Europe Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2020-2031)
8.3 Europe Classical Swine Fever Vaccines 麻豆原创 Size by Country
8.3.1 Europe Classical Swine Fever Vaccines Sales Quantity by Country (2020-2031)
8.3.2 Europe Classical Swine Fever Vaccines Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Source (2020-2031)
9.2 Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2020-2031)
9.3 Asia-Pacific Classical Swine Fever Vaccines 麻豆原创 Size by Region
9.3.1 Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Classical Swine Fever Vaccines Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Classical Swine Fever Vaccines Sales Quantity by Source (2020-2031)
10.2 South America Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2020-2031)
10.3 South America Classical Swine Fever Vaccines 麻豆原创 Size by Country
10.3.1 South America Classical Swine Fever Vaccines Sales Quantity by Country (2020-2031)
10.3.2 South America Classical Swine Fever Vaccines Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Source (2020-2031)
11.2 Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2020-2031)
11.3 Middle East & Africa Classical Swine Fever Vaccines 麻豆原创 Size by Country
11.3.1 Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Classical Swine Fever Vaccines Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Classical Swine Fever Vaccines 麻豆原创 Drivers
12.2 Classical Swine Fever Vaccines 麻豆原创 Restraints
12.3 Classical Swine Fever Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Classical Swine Fever Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Classical Swine Fever Vaccines
13.3 Classical Swine Fever Vaccines Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Classical Swine Fever Vaccines Typical Distributors
14.3 Classical Swine Fever Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
WINSUN
Merck
CAHIC
Tecon
SPAH
Boehringer Ingelheim
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
听
听
*If Applicable.
